BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30649377)

  • 21. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
    Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
    Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group).
    Kato D; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Asian J Endosc Surg; 2022 Oct; 15(4):745-752. PubMed ID: 35508895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens.
    Mori K; Sharma V; Comperat EM; Sato S; Laukhtina E; Schuettfort VM; Pradere B; Parizi MK; Karakiewicz PI; Egawa S; Tilki D; Boorjian SA; Shariat SF
    Eur J Surg Oncol; 2021 May; 47(5):1172-1178. PubMed ID: 33371950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
    Kır G; Seneldir H; Gumus E
    Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of greater short-term PSA recurrence with laparoscopic as compared to retropubic radical prostatectomy for Japanese clinically localized prostate carcinomas.
    Akita H; Okamura T; Ando R; Nagata D; Naruyama H; Yamada Y; Naiki T; Yasui T; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(11):2959-61. PubMed ID: 22393971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomy.
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kato D; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    BJUI Compass; 2022 Sep; 3(5):392-399. PubMed ID: 35950038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates.
    Altok M; Troncoso P; Achim MF; Matin SF; Gonzalez GN; Davis JW
    Asian J Androl; 2019; 21(6):598-604. PubMed ID: 31115364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
    Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
    Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.
    Huang JG; Pedersen J; Hong MK; Harewood LM; Peters J; Costello AJ; Hovens CM; Corcoran NM
    BJU Int; 2013 May; 111(6):921-7. PubMed ID: 23350712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.
    Kim DK; Koo KC; Lee KS; Hah YS; Rha KH; Hong SJ; Chung BH
    J Korean Med Sci; 2018 Nov; 33(45):e285. PubMed ID: 30402050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Propensity score comparison of the various radical surgical techniques for high-risk prostate cancer].
    Busch J; Gonzalgo M; Leva N; Ferrari M; Friedersdorff F; Hinz S; Kempkensteffen C; Miller K; Magheli A
    Aktuelle Urol; 2015 Jan; 46(1):45-51. PubMed ID: 25526221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.
    Viers BR; Sukov WR; Gettman MT; Rangel LJ; Bergstralh EJ; Frank I; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
    Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar Recurrence Rate Between Gleason Score of Six at Positive Margin and Negative Margin After Radical Prostatectomy.
    Kano H; Kadono Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Ikeda H; Mizokami A
    Anticancer Res; 2021 Jan; 41(1):509-516. PubMed ID: 33419850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.